コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 NMR structure of the analogous domain of the corticotropin-releasing factor receptor.
2 The CRF system consists of two receptors, corticotropin releasing factor receptor 1 (CRF1R) and co
7 We aimed to characterize the effects of the corticotropin-releasing factor receptor 1 (CRF-R1) antag
8 noradrenergic (NE) receptors (alpha1) via a corticotropin-releasing factor receptor 1 (CRF-R1)-depen
9 rial evaluating the efficacy of GSK561679, a corticotropin-releasing factor receptor 1 (CRF1 receptor
11 re to examine the effects of nicotine in VTA corticotropin-releasing factor receptor 1 (CRF1) neurons
14 Similarly to what has been observed for the corticotropin-releasing factor receptor 1 (CRFR1), SAP97
15 me proliferator-activated receptor gamma and corticotropin-releasing factor receptor 1 were notable e
16 ecifically activated by either neurokinin I, corticotropin-releasing factor receptor 1, or dopamine D
17 tuted pyridyl)pyrazolo[1,5-a]-1,3,5-triazine corticotropin releasing factor receptor-1 (CRF(1)) recep
18 methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazine corticotropin releasing factor receptor-1 (CRF(1)) recep
19 ing affinity of 4-anilinopyrimidines against corticotropin-releasing factor receptor-1 (CRF(1)) (e.g.
21 n in the BNST is unaffected by alpha1-AR and corticotropin-releasing factor receptor-1 (CRFR(1)) anta
22 Effects on attention were attenuated by the corticotropin-releasing factor receptor-1 antagonist ant
24 opin releasing factor receptor 1 (CRF1R) and corticotropin releasing factor receptor 2 (CRF2R), a non
25 analysis showed significant upregulation of corticotropin releasing factor receptor 2 (CrfR2) in the
28 duction of melanogenesis; this suggests that corticotropin releasing factor receptor alternative spli
29 cyclic imidazo[4,5-b]pyridin-2-ones as human corticotropin-releasing factor receptor (CRF(1)) antagon
30 ss, the physiological consequence of central corticotropin-releasing factor receptor (CRF-R) activati
32 n and structural characterization of the rat corticotropin releasing factor receptor (CRFR) gene was
33 viously reported differential involvement of corticotropin-releasing factor receptor (CRFR) 1 and 2 i
38 mutants with constitutive activation of the corticotropin-releasing factor receptor family homologue
40 anaphylaxis and psychological stress through corticotropin-releasing factor receptor subtype 1 (CRF(1
41 In this study we investigated the role of corticotropin-releasing factor receptor subtype 2 (CRF(2
43 nvestigated here the interaction between the corticotropin releasing factor receptor type 1 (CRF1R) a
45 d, we took the CRF(2(a))R and the homologous corticotropin-releasing factor receptor type 1 (CRF(1)R)
46 esent study investigated whether blockade of corticotropin-releasing factor receptor type 1 (CRF-R1)
47 n reflect reductions in anandamide driven by corticotropin-releasing factor receptor type 1 (CRF1) po
48 we investigated interactions of the class B corticotropin-releasing factor receptor type 1 (CRF1R) w
51 ular membrane compartments, we show that the corticotropin-releasing factor receptor type 1 has a spe
52 ure of the transmembrane domain of the human corticotropin-releasing factor receptor type 1 in comple
56 The physiological consequences of activating corticotropin-releasing factor receptor type 2 (CRF2) ar
57 vation of the central stress response, while corticotropin-releasing factor receptor type 2 (CRFR2) h
59 eviously, we observed abnormal expression of corticotropin-releasing factor receptor type 2 (CRFR2) t